Day One Biopharmaceuticals, Inc.
DelistedCIK 1845337fmd_0P0P9Q79CXSVK6ZTNAX6CBRV72Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2025, 25 periods
Latest annual · FY2025
Millions- Total revenues
- 158
- Operating income
- (128)
- Net income
- (107,322)
- Free cash flow
- (104)
Latest quarter · Q4 FY2025
Millions- Total revenues
- 54
- Operating income
- (27)
- Net income
- (107,236)
- Free cash flow
- (14)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- n/m
- Revenue, 5 yearsFY2020 to FY2025
- n/m
- Net income, 5 yearsFY2020 to FY2025
- n/m
Day One Biopharmaceuticals, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $158.2 million | $131.2 million | +20.6% | 10-K 2026-02-24 · proof |
| Operating income | -$127.8 million | -$217.3 million | 10-K 2026-02-24 · proof | |
| Net income | -$107.3 billion | -$95.5 billion | 10-K/A 2026-04-17 · proof | |
| Cash from operating activities | -$103.8 million | -$78.1 million | 10-K 2026-02-24 · proof | |
| Free cash flow | -$104.1 million | -$80.3 million | 10-K 2026-02-24 · proof | |
| Total assets | $507.8 million | $582.8 million | -12.9% | 10-K 2026-02-24 · proof |
| Total liabilities | $66.7 million | $80 million | -16.7% | 10-K 2026-02-24 · proof |
| Cash and cash equivalents | $197.1 million | $125 million | +57.7% | 10-K 2026-02-24 · proof |
- What was Day One Biopharmaceuticals, Inc.'s revenue in fiscal 2025?
- Day One Biopharmaceuticals, Inc. reported revenue of $158.2 million for fiscal 2025 (the year ended Dec 31, 2025), against $131.2 million the year before (+20.6%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
- What was Day One Biopharmaceuticals, Inc.'s operating income in fiscal 2025?
- Day One Biopharmaceuticals, Inc. reported operating income of -$127.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$217.3 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
- What was Day One Biopharmaceuticals, Inc.'s net income in fiscal 2025?
- Day One Biopharmaceuticals, Inc. reported net income of -$107.3 billion for fiscal 2025 (the year ended Dec 31, 2025), against -$95.5 billion the year before. Source: the 10-K/A filed with the SEC on Apr 17, 2026 (restated). SEC
- What was Day One Biopharmaceuticals, Inc.'s cash from operating activities in fiscal 2025?
- Day One Biopharmaceuticals, Inc. reported cash from operating activities of -$103.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$78.1 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
- What was Day One Biopharmaceuticals, Inc.'s free cash flow in fiscal 2025?
- Day One Biopharmaceuticals, Inc. reported free cash flow of -$104.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$80.3 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
- What are Day One Biopharmaceuticals, Inc.'s total assets?
- As of Dec 31, 2025, Day One Biopharmaceuticals, Inc. reported total assets of $507.8 million, against $582.8 million a year earlier (-12.9%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
- What are Day One Biopharmaceuticals, Inc.'s total liabilities?
- As of Dec 31, 2025, Day One Biopharmaceuticals, Inc. reported total liabilities of $66.7 million, against $80 million a year earlier (-16.7%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
- What are Day One Biopharmaceuticals, Inc.'s cash and cash equivalents?
- As of Dec 31, 2025, Day One Biopharmaceuticals, Inc. reported cash and cash equivalents of $197.1 million, against $125 million a year earlier (+57.7%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1845337&period_type=annual&limit=5"Information only, not investment advice.